- Diagnostics
- Friday, 05 Jun 2020
Japan to have coronavirus vaccines in use by June 2021
Drugmakers around the world are scrambling to develop a treatment or vaccine for COVID-19, the respiratory disease caused by the highly infectious new coronavirus which has so far killed nearly 400,000 people worldwide.
“We will be securing production facilities in parallel with expedited vaccine development,” Japan’s Health Minister Katsunobu Kato told reporters as he outlined plans to bring vaccines into use by the end of the first half of 2021.
Usually, plants for actual vaccine production are arranged only after the successful completion of development.
The Japanese government has earmarked 146 billion yen ($1.34 billion) for vaccine production and distribution in the second extra budget that Prime Minister Shinzo Abe’s cabinet approved last month.
Japanese pharmaceutical firms developing coronavirus vaccines include Shionogi & Co and AnGes Inc.
Related Industry Updates
$4.6m Awarded for Clinical Trials at Northwell's Cancer Institute
Oct 16, 2019
New Noninvasive Nutritional Testing with Metabolomix+
Jun 25, 2020
CVS Health to Significantly Expand COVID-19 Testing Capabilities
Apr 28, 2020
Curavit Clinical Research officially launches with a focus on virtual trials
Feb 18, 2020
Leader of leading Rare Disease Company (CENTOGENE) enters in the Finals of EY Entrepreneur of the Year 2019
Sep 23, 2019
Viracor Eurofins Launches Highly Accurate Antibody Tests for Coronavirus (COVID-19) SARS-CoV-2
May 08, 2020
Hangzhou Realy IgG/IgM Rapid Test Device Deployed to Global Market
May 11, 2020
Follow us on
